Dopson Pharma (India) Limited
About Dopson Pharma (India) Limited
Data last updated:
Dopson Pharma (India) Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the brokerage and trading services segment of the financial services sector. It was incorporated on 19 March 1982 and has been in existence for over 44 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1982PLC026712. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹6 Cr. It is led by directors including Kuldeep Agrawal and Anil Mangal.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at G5/701 Garden Crest Chs Ltd. West Avenue Santacruz West Mumbai, Maharashtra, India – 400054.
As per MCA filings, the company has satisfied charges of ₹91.25 Lakh on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Dopson Pharma (India) has one previous CIN (Corporate Identification Number): U99999MH1982PTC026712. The current CIN is U99999MH1982PLC026712, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999MH1982PLC026712 | Current |
| U99999MH1982PTC026712 | Previous |
Contact details
Dopson Pharma (India) Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressG5/701 Garden Crest Chs Ltd. West Avenue Santacruz West Mumbai, Maharashtra, India – 400054
- IndustryFinancial Services, Brokerage & Trading Services
To see the full contact details of Dopson Pharma (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Dopson Pharma (India) Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dopson Pharma (India) Limited, buy the company report.
Board of directors of Dopson Pharma (India) Limited
Dopson Pharma (India) has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kuldeep Agrawal | Director | 29 Jun 2011 | 15 Years 4 Months | Current |
| Anil Mangal Also directs: New World Medical (India) Limited, Mangal Auto Private Limited | Additional Director | 20 Apr 2017 | 9 Years 6 Months | Current |
| Chetan Vinod Palikar | Additional Director | 20 Mar 2020 | 6 Years 7 Months | Current |
Auditor
Dopson Pharma (India) Limited is audited by ATUL VEERESH & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL VEERESH & ASSOCIATES | FY 2018 | 121768W |
Shareholding
The shareholding of Dopson Pharma (India) Limited is on record for 5 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dopson Pharma (India) Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Mar 2000 | 90364399 | Corporation Bank | ₹85 Lakh | Satisfied | |
| 10 Mar 1986 | 90362897 | Canara Bank | ₹1.75 Lakh | Satisfied | |
| 10 Mar 1983 | 90362508 | Canara Bank | ₹3 Lakh | Satisfied | |
| 15 Oct 1982 | 90362463 | Canara Bank | ₹1.5 Lakh | Satisfied |
To see the full charge records of Dopson Pharma (India) Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Dopson Pharma (India) Limited has 8 court cases on record: 2 filed by Dopson Pharma (India), 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 5 | 0 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed by the company against an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Registrar of Companies | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP1) | Filed against the company by an individual | Disposed |
| Bombay High Court | Court case (CHS) | Filed against the company by an individual | Disposed |
To see the full case history of Dopson Pharma (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dopson Pharma (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dopson Pharma (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Dopson Pharma (India) Limited, buy the company report.
Recent activity
Dopson Pharma (India) Limited has 10 board changes on record since 2011: 3 appointments and 7 cessations. The latest: Bhaskar Achhelal Yadav ceased to be Additional Director on 20 Mar 2020.
9 earlier events are in the company report.
Frequently asked questions
Dopson Pharma (India) is an active public limited company based in Mumbai, Maharashtra, India. The company works in brokerage and trading services, within the financial services industry. It was incorporated on 19 March 1982 (44+ years old) and is registered under CIN U99999MH1982PLC026712.
Dopson Pharma (India) has 3 current directors:
- Kuldeep Agrawal - Director
- Anil Mangal - Additional Director
- Chetan Vinod Palikar - Additional Director
The latest financial statements of Dopson Pharma (India) on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
No. Dopson Pharma (India) has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Dopson Pharma (India) is U99999MH1982PLC026712. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dopson Pharma (India) has 8 court cases on record: 2 filed by the company and 6 filed against it. Most are in the district courts.
Dopson Pharma (India) was incorporated on 19 March 1982, making it 44+ years old. It is registered with the Registrar of Companies, Mumbai.
Bhaskar Achhelal Yadav ceased to be Additional Director on 20 Mar 2020. Chetan Vinod Palikar was appointed as Additional Director on 20 Mar 2020. Govind Keshav Purbia ceased to be Director on 25 Mar 2019. Dopson Pharma (India) has 10 board changes on record in total.
The registered office of Dopson Pharma (India) is at G5701 Garden Crest Chs Ltd. West Avenue Santacruz West Mumbai, Maharashtra, India – 400054.
Dopson Pharma (India) operates in the financial services industry, in the brokerage and trading services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
